WO2019074214A3 - 황산염을 포함하는 대장 하제 조성물 - Google Patents

황산염을 포함하는 대장 하제 조성물 Download PDF

Info

Publication number
WO2019074214A3
WO2019074214A3 PCT/KR2018/010678 KR2018010678W WO2019074214A3 WO 2019074214 A3 WO2019074214 A3 WO 2019074214A3 KR 2018010678 W KR2018010678 W KR 2018010678W WO 2019074214 A3 WO2019074214 A3 WO 2019074214A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
colonic purgative
sulfate
composition containing
dose
Prior art date
Application number
PCT/KR2018/010678
Other languages
English (en)
French (fr)
Other versions
WO2019074214A9 (ko
WO2019074214A2 (ko
Inventor
남봉길
정현정
윤현숙
박종수
Original Assignee
주식회사 한국팜비오
남봉길
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66101355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2019074214(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 주식회사 한국팜비오, 남봉길 filed Critical 주식회사 한국팜비오
Publication of WO2019074214A2 publication Critical patent/WO2019074214A2/ko
Publication of WO2019074214A3 publication Critical patent/WO2019074214A3/ko
Publication of WO2019074214A9 publication Critical patent/WO2019074214A9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 무수황산마그네슘, 황산칼륨, 무수황산나트륨을 포함하고, 추가로 시메치콘을 포함하는 것을 특징으로 하는 대장하제이다. 본 발명은 무수황산마그네슘, 황산칼륨, 무수황산나트륨으로 구성된 종래 대장하제에 비해 복용량을 최대 약 20% 가까이 줄여도, 만족스러운 대장 정결효과가 나타난다. 또한 본 발명은 종래 제품보다 복용량을 줄였기 때문에, 주성분에 의한 역한 맛이나 냄새가 덜하고, 제제와 물의 섭취량이 적어, 복약순응도가 상당히 개선되었다.
PCT/KR2018/010678 2017-10-12 2018-09-12 황산염을 포함하는 대장 하제 조성물 WO2019074214A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170132565A KR102127003B1 (ko) 2017-10-12 2017-10-12 황산염을 포함하는 대장 하제 조성물
KR10-2017-0132565 2017-10-12

Publications (3)

Publication Number Publication Date
WO2019074214A2 WO2019074214A2 (ko) 2019-04-18
WO2019074214A3 true WO2019074214A3 (ko) 2019-05-31
WO2019074214A9 WO2019074214A9 (ko) 2019-08-08

Family

ID=66101355

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/010678 WO2019074214A2 (ko) 2017-10-12 2018-09-12 황산염을 포함하는 대장 하제 조성물

Country Status (2)

Country Link
KR (1) KR102127003B1 (ko)
WO (1) WO2019074214A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102111094B1 (ko) 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
WO2022146089A1 (ko) * 2020-12-31 2022-07-07 주식회사태준제약 장세척을 위한 경구용 고형제제
KR102467063B1 (ko) * 2021-02-26 2022-11-14 주식회사태준제약 장세척을 위한 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
KR20150089430A (ko) * 2014-01-28 2015-08-05 주식회사한국파마 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2782581A4 (en) * 2011-10-27 2015-05-20 Salix Pharmaceuticals Inc ELEKTROLYT laxatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
KR20150089430A (ko) * 2014-01-28 2015-08-05 주식회사한국파마 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOHNSON, D. A.: "Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer", THE AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 109, no. 10, October 2014 (2014-10-01), pages 1528 - 1545, XP055619346 *
LOPES, T.: "Efficacy and tolerability of suprep with and without simethicone for routine colonoscopy for colorectal cancer screening", CLINICALTRIAL.GOV IDENTIFIER NCT02523911, 29 August 2017 (2017-08-29), pages 1 - 5, XP055619334, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/show/NCT02523911> *
TONGPRASERT, S.: "Improving quality of colonoscopy by adding simethicone to sodium phosphate bowel preparation", WORLD JOURNAL OF GASTROENTEROLOGY, vol. 15, no. 24, 28 June 2009 (2009-06-28), pages 3032 - 3037, XP055619350 *

Also Published As

Publication number Publication date
WO2019074214A9 (ko) 2019-08-08
KR102127003B1 (ko) 2020-06-25
KR20190041233A (ko) 2019-04-22
WO2019074214A2 (ko) 2019-04-18

Similar Documents

Publication Publication Date Title
WO2019074214A3 (ko) 황산염을 포함하는 대장 하제 조성물
HRP20192299T1 (hr) Liječenje nafld i nash
MX2017013535A (es) Metodos y composiciones de limpieza personal concentradas.
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
MX2019005533A (es) Tratamiento de la fibrosis.
PE20150092A1 (es) Composiciones farmaceuticas que contienen fumarato de dimetilo
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
MX2020007902A (es) Carbonato de calcio tratado mediante reaccion superficial para usar como modificador de la apariencia de la piel.
WO2013183062A3 (en) Palatable formulations of ibuprofen
EA201171088A1 (ru) Лечение дискинезии при различных расстройствах
PE20070828A1 (es) Composicion farmaceutica que contiene una sal de glicopirronio
WO2018111315A8 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
MX2022001144A (es) Metodos y composiciones para modular la microbiota intestinal y para manejar el peso.
EA201500576A1 (ru) Мягкие антибактериальные очищающие композиции
MX2021014121A (es) Composicion liquida para limpieza personal.
EA200600626A1 (ru) Композиция и лекарственная форма продолжительного выделения леводопы
BR112015019776A2 (pt) comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos
MX2020014262A (es) Composicion farmaceutica que comprende un agente basico poco soluble.
ZA202108010B (en) Lamellar liquid cleansers comprising acyl isethionate and methyl acyl taurate surfactant mixtures
MX356373B (es) Composiciones que comprenden un agente antibacterial y tazobactam.
PH12020552098A1 (en) Solid preparation composition for oral application of colonic purgative containing anhydrous sodium sulfate, potassium sulfate, anhydrous magnesium sulfate, and simethicone
CA2880108C (en) Uses of compositions containing a roasted extract and xanthohumol
EP4017880A4 (en) USE OF BRAZIKUMAB TO TREAT CROHN&#39;S DISEASE
RU2015115159A (ru) Лечебно-профилактическая композиция для ухода за полостью рта гематоонкологических больных
WO2019016673A3 (en) STABLE PHARMACEUTICAL COMPOSITION OF ORAL ADMINISTRATION OF IMATINIB

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18866129

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18866129

Country of ref document: EP

Kind code of ref document: A2